تقرير
أعرض في EDS

Increased mortality risk in multiple-myeloma patients with subsequent malignancies: a population-based study in the Netherlands.

التفاصيل البيبلوغرافية
العنوان: Increased mortality risk in multiple-myeloma patients with subsequent malignancies: a population-based study in the Netherlands.
المؤلفون: Brink M; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. m.brink@iknl.nl., Minnema MC; Department of Hematology, Cancer Center, UMC Utrecht, Utrecht, The Netherlands., Visser O; Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Posthuma EFMW; Department of Internal Medicine, Reinier de Graaf Group, Delft, The Netherlands., Broijl A; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van der Klift M; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands., Roeloffzen WWH; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Westerman M; Department of Internal Medicine, Northwest Clinics, Alkmaar, the Netherlands., van Rooijen CR; Department of Hematology, Medical Center Twente, Enschede, The Netherlands., Geerts PAF; Department of Hematology, Isala Hospital, Zwolle, The Netherlands., Zweegman S; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands., van de Donk NWCJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Dinmohamed AG; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.
المصدر: Blood cancer journal [Blood Cancer J] 2022 Mar 15; Vol. 12 (3), pp. 41. Date of Electronic Publication: 2022 Mar 15.
نوع المنشور: Letter; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
أسماء مطبوعة: Original Publication: New York, NY : Nature Pub. Group
مواضيع طبية MeSH: Multiple Myeloma*/epidemiology , Neoplasms, Second Primary*, Humans ; Netherlands/epidemiology
References: N Engl J Med. 2012 May 10;366(19):1782-91. (PMID: 22571202)
N Engl J Med. 2014 Sep 4;371(10):895-905. (PMID: 25184862)
Best Pract Res Clin Haematol. 2020 Mar;33(1):101144. (PMID: 32139010)
J Clin Oncol. 2017 Oct 10;35(29):3279-3289. (PMID: 28742454)
N Engl J Med. 2011 Dec 8;365(23):2241-2. (PMID: 22150057)
Br J Haematol. 2018 Aug;182(4):513-520. (PMID: 29974936)
Biol Blood Marrow Transplant. 2013 Nov;19(11):1615-24. (PMID: 23939198)
Haematologica. 2015 Oct;100(10):1340-9. (PMID: 26160877)
Leukemia. 2021 Aug;35(8):2145-2150. (PMID: 34012133)
Eur J Haematol. 2021 Aug;107(2):275-282. (PMID: 33966293)
Haematologica. 2014 Feb;99(2):232-42. (PMID: 24497560)
Lancet Oncol. 2014 Mar;15(3):333-42. (PMID: 24525202)
Blood Cancer J. 2013 Jun 28;3:e121. (PMID: 23811785)
Blood Rev. 2021 Mar;46:100757. (PMID: 32972803)
Blood Adv. 2017 Nov 22;1(25):2392-2398. (PMID: 29296889)
تواريخ الأحداث: Date Created: 20220316 Date Completed: 20220405 Latest Revision: 20220509
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC8924210
DOI: 10.1038/s41408-022-00640-6
PMID: 35292622
قاعدة البيانات: MEDLINE
الوصف
تدمد:2044-5385
DOI:10.1038/s41408-022-00640-6